Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: Intragastric distribution of colonization and gastric mucosal atrophy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 7, 1998, Pages 725-731

  Saita, Hiroshi ^a   Murakami, Motonobu ^b   Takahashi, Youji ^a   Sou, Yasunari ^a   Kaitani, Kazuaki ^a   Nishio, Kiyoshi ^a   Kita, Toru ^b  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Amoxycillin; Gastric mucosal atrophy; Helicobacter pylori; Helicobacter pylori distribution; Lansoprazole; Peptic ulcer

Indexed keywords

AMOXICILLIN; LANSOPRAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; FEMALE; GASTRIC MUCOSA ATROPHY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH MUCOSA LESION; STOMACH ULCER;

EID: 0031722844     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00721.x     Document Type: Article

References (38)

1. Marshall BJ, Goodwin CS, Warren JR et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-42.
2. Rauws EAJ, Tytgat GNL. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 1: 1233-5.
3. Patchett S, Beattie S, Leen E, Keane C, O'Morain C. Helicobacter pylori and duodenal ulcer recurrence. Am. J. Gastroenterol. 1992; 87: 24-7.
4. Graham DY, Lew GM, Klein PD et al. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric or duodenal ulcer. Ann. Intern. Med. 1992; 116: 705-8.
5. Alper J. Ulcers as an infectious disease. Science 1993; 260: 159-60.
6. Borody TJ, Cole P, Noonan S et al. Recurrence of duodenal ulcer and Campylobacter pylon infection after eradication. Med. J. Aust. 1989; 151: 431-5.
7. George LL, Borody TJ, Andrews P et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med. J. Aust. 1990; 153: 145-9.
8. Chiba N, Rao BV, Rademaker JW, Hunt RH. Metaanalysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am. J. Gastroenterol. 1992; 87: 1716-27.
9. Thijs JC, Van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand. J. Gastroenterol. 1993; 28: 934-8.
10. Bell GD, Powell K, Burridge SM et al. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment. Pharmacol. Ther. 1992; 6: 427-35.
11. Borody T, Cole P, Noonan S, Ossip J, Maysey J, Brandi S. Long-term Campylobacter recurrence post-eradication. Gastroenterology 1988; 94: A43.
12. Graham DY, Lew GM, Malaty HM et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
13. Hosking SW, Ling TKW, Chung SCS et al. Duodenal ulcer healing by eradication of H. pylori without antacid treatment: Randomized controlled trial. Lancet 1994; 343: 508-10.
14. Lind T, Zantan SV, Unge P et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials. The MACH 1 study. Helicobacter 1996; 1: 138-44.
15. Bayerdörfter E, Mannes GA, Sommer A et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylon. Eur. J. Gastroenterol. 1992; 4: 697-702.
16. Labenz J, Gyenes E, Rühl GH, Börsch G. Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori. Gastroenterology 1992; 30: 776-8.
17. Labenz J, Börsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994; 35: 19-22.
18. Adamek RJ, Wegener M, Labenz J, Freitag M, Opferkuch W, Rühl GH. Medium-term results of oral and intravenous omeprazole amoxicillin Helicobacter pylori eradication therapy. Am. J. Gastroenterol. 1994; 89: 39-42.
19. Satoh H, Inatomi N, Nagaya H et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J. Pharmacol. Exp. Ther. 1989; 248: 806-15.
20. Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells. Pharmacol. Exp. Ther. 1990; 252: 1289-95.
21. Iwahi T, Satoh H, Nakao M et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob. Agents Chemother. 1991; 35: 490-6.
22. Nagata K, Satoh N, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: Unique action selective for H. pylori cells. Antimicrob. Agents Chemother. 1993; 37: 769-74.
23. Schindler R, Ortmayer P. Classification of chronic gastritis with special reference to the gastroscopic method. Arch. Intern. Med. 1936; 57: 959-78.
24. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1: 87-97.
25. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis: The updated Sydney System. Am. J. Surg. Pathol. 1996; 20: 1161-81.
26. De Korwin JD, Joubert M, Bazin N, Thiaucourt D, Protte E. Lansoprazole versus lansoprazole plus antibiotics in the treatment of Helicobacter pylori gastric infection. Gastroenterology 1993; 104: A67.
27. Soule JC, Courrier A, Bigard MA et al. Efficacy of lansoprazole plus one or two antibiotics for Helicobacter pylori eradication. Gastroenterology 1995; 108: A224.
28. Labenz J, Gyenes E, Rühl GH, Börsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: A prospective, randomized, and controlled study. Gut 1993; 34: 1167-70.
29. Unge P, Gad A, Erksson K et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur. J. Gastroenterol. Hepatol. 1993; 5: 325-31.
30. Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am. J. Gastroenterol. 1990; 85: 1545-51.
31. Labenz J, Leverkus F, Börsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand. J. Gastroenterol. 1994; 29: 1070-5.
32. Labenz J, Stolte M, Blum AL et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: A study in peptic ulcer patients with omeprazole and amoxicillin. Gut 1995; 37: 39-43.
33. Graham KS, Malaty H, El-Zimaity MT et al Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 1995; 90: 1415-18.
34. McNulty CAM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and Gastroduodenal Disease. Oxford: Blackwell Scientific Publications, 1989; 209-16.
35. Moshkowitz M, Konikoff FM, Peled Y et al. High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 1995; 36: 845-7.
36. Dixon MF. Helicobacter pylori and peptic ulceration: Histopathological aspects. J. Gastroenterol Hepatol 1991; 6: 125-30.
37. Mannes GA, Bäyerdorffer E, Hele C, Ruckdeschel G, Stolte M. An increasing dose of omeprazole combined with amoxicillin increases the eradication rate of Helicobacter pylori. Gastroenterology 1993; 104: 140.
38. Logan RPH, Misiewicz JJ, Gummett P, Karim QN, Walker M, Baron J. The dose and frequency of omeprazole are important in treating H. pylori with dual therapy. Gastroenterology 1993; 104: A186.